Uncategorized

Daiichi eyes almost $15B in oncology sales by 2030 in ADC franchise push

Published

on

Daiichi Sankyo is betting on its oncology franchise to push it past 3 trillion Japanese yen ($19 billion) in 2030 revenues.

The drugmaker published a new five-year business plan on Monday …

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version